|
Ãö©ó°Ñ¥[
|
¬°´Á1¶g¤§BioMedical Asia¬O¨È¬w¥Íª«Âå¾Ç·~¬É³Ì¨ã¥Nªí¤§¬¡°Ê¡C
¦¹¬¡°Ê´£¨Ñ°ê»Ú©Ê©Î¦a°ì©Ê¤§»sÃÄ¥ø·~¡B¥Íª«¬ì§Þ¥ø·~¡B¬ã¨s¾÷Ãö¡B¥DºÞ¾÷Ãö¡B§ë¸ê®a¡BÂå®v¤Î¨ä¥¦¦U¬É¬ÛÃö¤H¤h¡A¤@Ó¤¬¬Û¥æ¬y³Ì·sµo²{¡A´M§ä¦X§@¾÷·|¡A¨ÃÀË°Q¥i¦æ°Ó·~pµe¤§³Ì¨Î³õ©Ò¡C
¦P®É¥]§t6Ó¥Dn·|ij¡B 7ºØ·~¬É¾É¦V¤§°ª®p·|ij¥H¤Î¤j®vÁ¿®yµ¥¡A BioMdical Asia¬°¨È¬w¥Íª«Âå¾Ç²[»\³Ì¼s¤§¬¡°Ê¡A±N§l¤Þ1000¤H¥H¤W¨ì³õ°Ñ¥[¡C
BioMdical Asia¤¤±N¥i¥H¥æ¬y°Q½×³Ì·s¦¨ªG¤Î·Qªk¡B¨Ã±q¨Æ°Ó·~¬¡°Ê¡A´M§ä¦X§@¤Î§ë¸êªº¥i¯à©Ê¡C
·|´Á¶¡¡A»P¶W¹L200¦ì°ê»ÚµÛ¦WÁ¿ªÌ¦@»E¤@°ó¡AÂǥѳoÓ¥¥x¥i¥H»P¦P·~¬Û¤¬¾Ç²ß»P¥æ¬y¡C·q½Ð°Ñ¥[¡C
>¸ß°Ý
>°Ñ¥[¥Ó½Ð
|
闗©ó®i¥XÃÙ§U
¦b¨È¬w³Ì¤j¥Íª«Âå¾Ç·~¬Éªº¬¡°Ê¤¤¡A¥´¶}¶Q¤½¥q¤§ª¾¦W«×¡C
Âǥѥͪ«Âå¾Ç§Þ³N¥DÃD®i¥Ü¥H¤Î¯S§O³W¹º¤§ªÀ¥æ¬¡°Êµ¥¡A¦¨¬°¶Q¤½¥q±À¾P·s»s«~¤Î·sªA°È¡A§í©Î¬O»PÅU«È°Ó½Í¤§³Ì¨Î»R¥x¡C
Life
|
ÁܽкtÁ¿
Gordon Binder is among biotech's most respected business minds, owing to his shepherding of Amgen to the world's largest biotech today. Mr Binder was former Chairman of both BIO and PhRMA, and currently sits on the boards of Massachusetts Institute of Technology, the California Insitute of Technology and the American Enterprise Institute
 Dr Gadicke originally trained as a physician and subsequently held post doctoral resarch positions at Harvard University and MIT. He previously spent 3 years with the Boston Consulting Group (BGG), where he worked with top management from pharmaceutical, diagnostic, biotechnology and health insurance companies
An eminent scientist and expert in molecular immunology and tumor immunity, Prof Kourilsky had a rapid scientific career both in the academic and corporate setting. He was also co-founder of Transgene, a gene therapy company based in France, and was the President of Research of Pasteur Merieux Connaught from 1993 - 1996
|
